Aaron Barkoff and Ben Mahon Featured in IAM Life Sciences: Key Issues for Life Sciences Executives 2020


In “Making sense of the doctrine of equivalents in pharmaceutical patent litigation,” Aaron Barkoff and Ben Mahon detail how companies should be mindful during prosecution of patent applications to avoid inadvertently surrendering claim scope and barring themselves from later relying on the doctrine of equivalents. Conversely, companies looking to design around competitors’ patents must study the specification and prosecution history carefully to determine how best to avoid risking infringement. Read the article here.